ProMIS Neurosciences, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
Notes Tables
Notes Details

PREPAID EXPENSES AND OTHER ASSETS

PREPAID EXPENSES AND OTHER ASSETS

3 Months Ended

Mar. 31, 2026

4.	PREPAID EXPENSES AND OTHER ASSETS

Prepaid expenses and other current assets consist of the following:


		March 31,			December 31,
		2026			2025
Upfront research payments		$	1,269,780		$	2,625,049
Accrued interest and other receivables			238,329			36,522
Insurance			148,750			238,000
License fees			90,225			62,059
Deferred financing costs			—			32,332
Other			17,510			38,150
Total prepaid expenses and other current assets		$	1,764,594		$	3,032,112

As of March 31, 2026 and December 31, 2025, the Company had $1,798,879 and $0, respectively, of prepaid expenses, long-term related to upfront research payments which were not expected to be recognized within 12 months of the period end date.